We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$245M
AUM Growth
+$18.2M
Cap. Flow
+$2.74M
Cap. Flow %
1.12%
Top 10 Hldgs %
66.41%
Holding
667
New
60
Increased
182
Reduced
81
Closed
82

Top Buys

Rank Stock Value
1
AXGN icon
Axogen
AXGN
+$3.91M
2
SIBN icon
SI-BONE Inc
SIBN
+$2.35M
3
NEO icon
NeoGenomics
NEO
+$1.8M
4
MASS icon
908 Devices
MASS
+$1.68M
5
HCAT icon
Health Catalyst
HCAT
+$1.18M

Top Sells

Rank Stock Value
1
PHLT
Performant Healthcare Inc
PHLT
+$5.84M
2
ANAB icon
AnaptysBio
ANAB
+$1.6M
3
INSM icon
Insmed
INSM
+$1M
4
ATEC icon
Alphatec Holdings
ATEC
+$740K
5
WFC icon
Wells Fargo
WFC
+$539K

Sector Composition

Rank Sector Weight
1 Healthcare 22.08%
2 Financials 4.47%
3 Technology 3.55%
4 Industrials 1.31%
5 Consumer Discretionary 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSLA icon
26
Tesla
TSLA
$1.43T
$1.3M 0.53%
2,881
+3
+0.1% +$1.33K
MASS icon
27
908 Devices
MASS
$302M
$1.27M 0.52%
+241,000
New +$1.68M
TWST icon
28
Twist Bioscience
TWST
$5.84B
$1.25M 0.51%
39,462
– –
IJJ icon
29
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.82B
$1.22M 0.5%
9,264
-23
-0.2% -$2.99K
IVE icon
30
iShares S&P 500 Value ETF
IVE
$48.8B
$1.22M 0.5%
5,736
-27
-0.5% -$5.66K
ATEC icon
31
Alphatec Holdings
ATEC
$1.31B
$1.14M 0.46%
54,120
-40,000
-42% -$740K
IWN icon
32
iShares Russell 2000 Value ETF
IWN
$14.4B
$1.09M 0.44%
6,022
-5
-0.1% -$898
XENE icon
33
Xenon Pharmaceuticals
XENE
$6.6B
$1.03M 0.42%
23,000
-3,100
-12% -$130K
CRNX icon
34
Crinetics Pharmaceuticals
CRNX
$8.88B
$1M 0.41%
21,495
+1,500
+8% +$66.8K
LQD icon
35
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35.2B
$986K 0.4%
8,952
+95
+1% +$10.6K
NPCE icon
36
Neuropace
NPCE
$548M
$973K 0.4%
63,000
– –
XEL icon
37
Xcel Energy
XEL
$49.2B
$960K 0.39%
13,001
+64
+0.5% +$5.05K
AGG icon
38
iShares Core US Aggregate Bond ETF
AGG
$139B
$948K 0.39%
9,496
+559
+6% +$56.1K
SPY icon
39
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$910K 0.37%
1,335
+157
+13% +$106K
USB icon
40
US Bancorp
USB
$98.4B
$902K 0.37%
16,898
+81
+0.5% +$3.98K
VTI icon
41
Vanguard Total Stock Market ETF
VTI
$658B
$827K 0.34%
2,468
+14
+0.6% +$4.66K
TNDM icon
42
Tandem Diabetes Care
TNDM
$1.17B
$772K 0.31%
35,120
+11,550
+49% +$208K
PG icon
43
Procter & Gamble
PG
$349B
$745K 0.3%
5,199
+36
+0.7% +$5.31K
SPEM icon
44
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$16.9B
$739K 0.3%
15,779
+79
+0.5% +$3.72K
HSBC icon
45
HSBC
HSBC
$345B
$709K 0.29%
9,008
– –
KRMD icon
46
KORU Medical Systems
KRMD
$189M
$703K 0.29%
120,935
– –
AUPH icon
47
Aurinia Pharmaceuticals
AUPH
$2.05B
$569K 0.23%
35,696
-2,000
-5% -$28.4K
ECL icon
48
Ecolab
ECL
$76.8B
$549K 0.22%
2,090
+2
+0.1% +$533
ABT icon
49
Abbott
ABT
$175B
$542K 0.22%
4,330
+20
+0.5% +$2.55K
OEF icon
50
iShares S&P 100 ETF
OEF
$20.1B
$527K 0.21%
1,538
– –
1
2
3 4 5

Similar funds

PPA
Pilgrim Partners Asia Singapore $246M AUM
IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return

HighMark Wealth Management's Q4 2025 Portfolio in Review

As of Q4 2025, HighMark Wealth Management held 667 positions worth $245M, up 8% from $227M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HighMark Wealth Management's Q4 2025 filing shows 60 new, 182 increased, 81 reduced and 82 closed positions. Its largest new stake was 908 Devices: 241,000 shares worth $1.27M. The largest sale was Performant Healthcare Inc, an estimated $5.84M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q4 2025 buy was 908 Devices: 241,000 shares worth $1.27M.
  • HighMark Wealth Management added most to Axogen in Q4 2025, an estimated $3.91M increase.
  • HighMark Wealth Management's biggest Q4 2025 reduction was AnaptysBio, cutting an estimated $1.6M.
  • HighMark Wealth Management fully exited Performant Healthcare Inc in Q4 2025, selling an estimated $5.84M.
  • HighMark Wealth Management's ten largest holdings make up 66% of its $245M portfolio in Q4 2025.
  • HighMark Wealth Management opened 60 new positions and closed 82 in Q4 2025.
  • HighMark Wealth Management's portfolio value rose 8% quarter-over-quarter to $245M.

Based on HighMark Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.